Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
Authors
Keywords
-
Journal
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume 41, Issue 6, Pages 544-563
Publisher
Wiley
Online
2015-01-26
DOI
10.1111/apt.13081
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection
- (2014) S. Saab et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hepatitis C virus: Here comes all-oral treatment
- (2014) M. DUGUM et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial
- (2014) Xavier Forns et al. GASTROENTEROLOGY
- Effects of Sustained Viral Response in Patients With HIV and Chronic Hepatitis C and Nonadvanced Liver Fibrosis
- (2014) Juan Berenguer et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141)
- (2014) Sylvie Deuffic-Burban et al. JOURNAL OF HEPATOLOGY
- Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
- (2014) Ira M Jacobson et al. LANCET
- Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Michael Manns et al. LANCET
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
- (2014) Eric Lawitz et al. LANCET
- Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
- (2014) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
- (2014) Nezam Afdhal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold
- (2014) Peter J. Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States
- (2013) Kerry Murphy et al. AIDS
- Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease
- (2013) S. C. Gordon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C
- (2013) Vincent Mallet et al. ANNALS OF INTERNAL MEDICINE
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
- (2013) Rebecca L. Morgan et al. ANNALS OF INTERNAL MEDICINE
- Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C
- (2013) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Similar Effectiveness of Boceprevir and Telaprevir Treatment Regimens for Hepatitis C Virus Infection on the Basis of a Nationwide Study of Veterans
- (2013) George N. Ioannou et al. Clinical Gastroenterology and Hepatology
- A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care
- (2013) Christopher E. McGowan et al. HEPATOLOGY
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
- (2013) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics
- (2013) Anuoluwapo Osinusi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients
- (2013) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Boceprevir for chronic HCV genotype 1 infection in patients with prior treatment failure to peginterferon/ribavirin, including prior null response
- (2013) John M. Vierling et al. JOURNAL OF HEPATOLOGY
- All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses
- (2013) L. M. Hagan et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
- (2013) Eric Lawitz et al. LANCET INFECTIOUS DISEASES
- Treatment of hepatitis C virus genotype 3-infection
- (2013) Stanislas Pol et al. LIVER INTERNATIONAL
- Second-wave IFN-based triple therapy for HCV genotype 1 infection: simeprevir, faldaprevir and sofosbuvir
- (2013) Tarik Asselah et al. LIVER INTERNATIONAL
- Hepatitis C in the United States
- (2013) Scott D. Holmberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C - a randomized trial
- (2013) Emilia Rusu et al. Nutrition Journal
- Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study
- (2012) Anne C. Moorman et al. CLINICAL INFECTIOUS DISEASES
- A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis
- (2012) Roberta D'Ambrosio et al. HEPATOLOGY
- Chronic hepatitis C virus (HCV) disease burden and cost in the United States
- (2012) Homie Razavi et al. HEPATOLOGY
- Distribution of hepatitis C virus genotypes in a diverse US integrated health care population
- (2012) M. Michele Manos et al. JOURNAL OF MEDICAL VIROLOGY
- Comparison of survival and quality of life of hepatectomy and thrombectomy using total hepatic vascular exclusion and chemotherapy alone in patients with hepatocellular carcinoma and tumor thrombi in the inferior vena cava and hepatic vein
- (2011) Jianping Liu et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C
- (2011) Jules L. Dienstag et al. HEPATOLOGY
- Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection
- (2011) Priscilla C Hsu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- PSI-7851, a Pronucleotide of -D-2'-Deoxy-2'-Fluoro-2'-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication
- (2010) A. M. Lam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver
- (2010) Ira M. Jacobson et al. Clinical Gastroenterology and Hepatology
- Insurance status and treatment candidacy of hepatitis C patients: Analysis of population-based data from the United States
- (2010) Maria Stepanova et al. HEPATOLOGY
- Interaction of alcohol intake and cofactors on the risk of cirrhosis
- (2010) Tommaso Stroffolini et al. LIVER INTERNATIONAL
- Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C
- (2008) Sarah Maylin et al. GASTROENTEROLOGY
- Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression
- (2008) Hla-Hla Thein et al. HEPATOLOGY
- Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review
- (2008) David J. McLernon et al. MEDICAL DECISION MAKING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation